What are the best practices for mitigating GMP risks in emerging markets?
Emerging markets offer great opportunities for pharmaceutical and biotech companies, but they also pose significant challenges in terms of quality management and compliance. Good Manufacturing Practice (GMP) is a set of standards and guidelines that ensure the quality, safety, and efficacy of drugs and medical devices. However, GMP regulations and enforcement vary widely across different regions and countries, creating potential risks for manufacturers and distributors. How can you mitigate these risks and ensure your products meet the highest quality standards in emerging markets? Here are some best practices to consider.